Evidence map›Paper›PMID 36780439›Full record

ArticlePloS one2023

Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.

Andreea Petrasca, Roisin Hambly, Oonagh Molloy, Sean Kearns, Barry Moran, Conor M Smith, Rosalind Hughes, Margaret O'Donnell, Alexandra Zaborowski, Desmond Winter and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. ILC3: a case of conflicted identity.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Andreea PetrascaSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Roisin HamblyDepartment of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Oonagh MolloyDepartment of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Sean KearnsSchool of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0003-3149-8641
Barry MoranSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Conor M SmithSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0003-1701-1665
Rosalind HughesDepartment of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Margaret O'DonnellPlastic and Reconstructive Surgery Department, St. Vincent's Private Hospital, Dublin, Ireland.
Alexandra ZaborowskiDepartment of Surgery, St. Vincent's University Hospital, Dublin, Ireland.
Desmond WinterDepartment of Surgery, St. Vincent's University Hospital, Dublin, Ireland.
Jean M FletcherSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Brian KirbyDepartment of Dermatology, St. Vincent's University Hospital, Dublin, Ireland.
Anna MalaraSchool of Medicine, University College Dublin, Dublin, Ireland.ORCID 0000-0002-1948-5568
St. Vincent's University Hospital · IETrinity College Dublin · IEUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease manifested as painful inflamed lesions including deep-seated nodules, abscesses and sinus tracts. The exact aetiology of HS is unclear. Recent evidence suggests that immune dysregulation plays a crucial role in pathogenesis and disease progression. Innate lymphoid cells (ILC) are a recently identified immune cell subset involved in mediating immunity, however their role in HS has not yet been investigated. Three distinct subsets of ILC- ILC1, ILC2 and ILC3 have been described, and these are involved in skin tissue homeostasis and pathologic inflammation associated with autoimmunity and allergic diseases. In this study, we analysed by multiparameter flow cytometry the frequencies of ILC subsets in skin and peripheral blood mononuclear cells (PBMC) of HS patients and compared these to healthy control subjects and psoriasis patients. The absolute numbers of total ILC and subsets thereof were significantly reduced in the blood of HS patients relative to healthy controls. However, when patients were stratified according to treatment, this reduction was no longer observed in patients undergoing anti-TNF treatment. In HS lesional skin the absolute numbers of ILC were significantly increased relative to control skin. Furthermore, the frequencies of total ILC as well as ILC2 and ILC3 were significantly higher in non-lesional than lesional HS skin. This study analysed for the first time the presence of ILC subsets in the blood and skin of HS patients. Our findings suggest that ILC may participate in HS pathogenesis.

Indexed as

Hidradenitis SuppurativaImmunity, InnateHumansInflammationLeukocytes, MononuclearLymphocytesTumor Necrosis Factor InhibitorsTumor Necrosis Factor Inhibitors

Identifiers

PMID36780439
PMCPMC9924995
OpenAlexW4320484239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.